Shares of Ardent Health, Inc. (NYSE:ARDT – Get Free Report) have earned a consensus rating of “Hold” from the fourteen brokerages that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $14.86.
ARDT has been the subject of several recent research reports. Wall Street Zen raised Ardent Health from a “hold” rating to a “buy” rating in a report on Saturday, November 7th. Mizuho set a $21.00 price objective on shares of Ardent Health in a report on Wednesday. Royal Bank Of Canada upped their price objective on shares of Ardent Health from $13.00 to $18.00 and gave the company an “outperform” rating in a report on Friday, November 6th. The Goldman Sachs Group reiterated a “neutral” rating and set a $13.00 target price on shares of Ardent Health in a research report on Thursday, August 6th. Finally, Guggenheim lifted their target price on shares of Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th.
View Our Latest Research Report on Ardent Health
Ardent Health Stock Up 0.4%
ARDT stock traded up $0.07 during midday trading on Friday, reaching $17.75. 779,496 shares of the company’s stock traded hands, compared to its average volume of 780,413. The company has a market cap of $2.50 billion, a price-to-earnings ratio of 17.24, a P/E/G ratio of 3.20 and a beta of 0.58. The firm’s fifty day moving average price is $12.14 and its 200-day moving average price is $10.33. The company has a quick ratio of 2.03, a current ratio of 2.13 and a debt-to-equity ratio of 0.60. Ardent Health has a 52 week low of $7.71 and a 52 week high of $18.57.
Ardent Health (NYSE:ARDT – Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported $0.31 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.08. The company had revenue of $1.62 billion for the quarter, compared to analyst estimates of $1.60 billion. Ardent Health had a return on equity of 8.41% and a net margin of 2.27%. As a group, sell-side analysts forecast that Ardent Health will post 1.05 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Ardent Health
Several large investors have recently added to or reduced their stakes in the business. Allworth Financial LP purchased a new position in shares of Ardent Health in the 2nd quarter worth about $28,000. Integrated Wealth Concepts LLC purchased a new position in shares of Ardent Health during the 2nd quarter valued at about $57,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Ardent Health during the 3rd quarter valued at about $61,000. Brighton Jones LLC bought a new stake in Ardent Health in the 3rd quarter worth approximately $110,000. Finally, Canada Pension Plan Investment Board bought a new stake in Ardent Health in the 2nd quarter worth approximately $118,000.
About Ardent Health
Ardent Health is a U.S. healthcare provider that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency services, surgery, and specialty and primary care through affiliated clinics and medical groups. The company serves communities in several states, including New Mexico, Oklahoma, and Texas. Its regional health systems include Lovelace Health System, Hillcrest HealthCare System, and UT Health East Texas. Ardent Health was formerly known as Ardent Health Services and became a publicly traded company in 2023.
Featured Articles
- Five stocks we like better than Ardent Health
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
